This inventor holds 8 USPTO granted patents. Top assignees: Scimed Life Systems, Inc., Boston Scientific Corporation, Boston Scientific Scimed, Inc.. Active years: 1995-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 1995-2010
Title: Innovations by Elizabeth A Stejskal
Introduction
Elizabeth A Stejskal is a prominent inventor based in Saint Paul, MN (US). She has made significant contributions to the field of medical devices, particularly in the development of biodegradable drug delivery systems. With a total of 8 patents to her name, her work has the potential to revolutionize patient care and treatment options.
Latest Patents
One of her latest innovations is the biodegradable drug delivery vascular stent. This stent features a main body of a generally tubular shape designed for insertion into a lumen of a vessel in a living being. The tubular main body is constructed from a substantially biodegradable matrix that incorporates collagen IV and laminin, enclosing voids within the matrix. Additionally, it includes a biodegradable strengthening material that enhances the matrix's durability. The stent is also essentially saturated with drugs, allowing for effective drug delivery.
Career Highlights
Throughout her career, Elizabeth has worked with notable companies such as Scimed Life Systems, Inc. and Boston Scientific Corporation. Her experience in these organizations has contributed to her expertise in medical device innovation and development.
Collaborations
Elizabeth has collaborated with several professionals in her field, including Paul J Buscemi and Donald F Palme, II. These partnerships have likely enriched her work and expanded the impact of her inventions.
Conclusion
Elizabeth A Stejskal's contributions to the field of medical devices, particularly through her innovative biodegradable drug delivery vascular stent, highlight her role as a leading inventor. Her work continues to pave the way for advancements in patient care and treatment methodologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile